PO:36:243 | Drug survival, discontinuation reasons and disease activity in patients with Behçet's disease treated with infliximab - a real-life study
Background. Behçet's Disease (BD) is a rare multisystemic vasculitis that can result in life-threatening manifestations when involving the central nervous system or vascular system. Infliximab (IFX) is an immunosuppressive drug widely used for the treatment of BD with major organ involvement or ref...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
PAGEPress Publications
2025-11-01
|
| Цуврал: | Reumatismo |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.reumatismo.org/reuma/article/view/2091 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|